|
Study of Anti-Survival signals in NF1
|
1R01CA153354-01A1
|
$361,050
|
$361,050
|
CHEN, CHANGYAN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Elucidating the Function of the NF1 Tumor Suppressor and its Effector Pathways in
|
5R01CA111754-08
|
$284,709
|
$284,709
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Role of gangliosides in tumor progression
|
5R01CA061010-17
|
$331,222
|
$248,417
|
LADISCH, STEPHAN
|
CHILDREN'S RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
2P30CA006516-47
|
$11,164,583
|
$111,646
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S1
|
$56,572
|
$566
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S2
|
$75,000
|
$750
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S3
|
$50,000
|
$500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-49S1
|
$115,518
|
$4,621
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-49S2
|
$140,000
|
$5,600
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-49S3
|
$170,000
|
$6,800
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-49S4
|
$75,000
|
$3,000
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
5P30CA006927-49
|
$4,061,662
|
$162,466
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Mechanisms of bHLH Mediated Lineage Specification
|
1K08CA169014-01
|
$158,910
|
$79,455
|
Fong, Abraham
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Neurofibromatosis type 1 Gene Regulates Myelopoiesis
|
5R01CA074177-15
|
$312,768
|
$312,768
|
CLAPP, DAVID
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-14S1
|
$107,715
|
$3,231
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-14S2
|
$75,000
|
$2,250
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
5P30CA082709-14
|
$1,237,416
|
$37,122
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
p21-Activated Kinases as New Therapeutic Targets in Neurofibromatosis Type 1
|
5R01CA142928-03
|
$395,129
|
$395,129
|
CHERNOFF, JONATHAN
|
INSTITUTE FOR CANCER RESEARCH
|
|
Molecular Function of the Nf2 Tumor Suppressor, Merlin
|
5R01CA113733-08
|
$331,162
|
$331,162
|
MCCLATCHEY, ANDREA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Research Management and Support - Total
|
RMS2012 [E]
|
$374,919,382
|
$389,916
|
N/A
|
(NCI)
|
|
Phospholipid and Sphingolipid Signaling in Drosophila
|
ZIABC010331
|
$494,758
|
$494,758
|
Acharya, Jairaj
|
CCR (NCI)
|
|
Sphingolipid Signaling in Mammals
|
ZIABC011187
|
$494,758
|
$494,758
|
Acharya, Jairaj
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIABC010030
|
$806,557
|
$80,656
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Protein Folding Mechanism
|
ZIABC010276
|
$258,211
|
$258,211
|
Bai, Yawen
|
CCR (NCI)
|
|
Investigation of the ABC Half-Transporter ABCG2
|
ZIABC010622
|
$226,824
|
$45,365
|
Bates, Susan
|
CCR (NCI)
|
|
Building Libraries with Chemical Diversity for Screening
|
ZIABC011469
|
$232,561
|
$46,512
|
Beutler, John
|
CCR (NCI)
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIABC011470
|
$232,561
|
$116,281
|
Beutler, John
|
CCR (NCI)
|
|
Studies of Histone Functions in Chromatin; H2AX and DNA DSBs
|
ZIABC006140
|
$938,201
|
$46,910
|
Bonner, William
|
CCR (NCI)
|
|
BKV and JCV vaccine development
|
ZIABC011460
|
$279,821
|
$83,946
|
Buck, Christopher
|
CCR (NCI)
|
|
The Cancer Genome Anatomy Project's Genetic Annotation Initiative
|
ZIABC011252
|
$40,487
|
$4,049
|
Buetow, Kenneth
|
CCR (NCI)
|
|
Bioinformatic Tools in Cancer Research
|
ZIHBC010470
|
$161,950
|
$16,195
|
Buetow, Kenneth
|
CCR (NCI)
|
|
Molecular Profiling of Patients Undergoing Radiotherapy
|
ZIASC010372
|
$541,815
|
$379,271
|
Camphausen, Kevin
|
CCR (NCI)
|
|
The Synergy Between Radiotherapy and Molecularly Targeted Agents
|
ZIASC010373
|
$812,723
|
$650,178
|
Camphausen, Kevin
|
CCR (NCI)
|
|
Radiation Oncology Branch - Radiation Clinic
|
ZIDBC010990
|
$4,669,845
|
$747,175
|
Camphausen, Kevin
|
CCR (NCI)
|
|
The Role of Pdcd4 in Translation, Tumorigenesis and Tumor Progression
|
ZIABC010026
|
$378,421
|
$75,684
|
Colburn, Nancy
|
CCR (NCI)
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIGBC010856
|
$14,609,987
|
$730,499
|
Custer, Mary
|
CCR (NCI)
|
|
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
|
ZIABC010006
|
$448,460
|
$89,692
|
Daar, Ira
|
CCR (NCI)
|
|
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
|
ZIABC010958
|
$448,460
|
$156,961
|
Daar, Ira
|
CCR (NCI)
|
|
CANCER AND INFLAMMATION GENETICS
|
ZIABC011300
|
$619,559
|
$61,956
|
Dean, Michael
|
CCR (NCI)
|
|
Clinical Pharmacogenetics
|
ZIABC010627
|
$435,929
|
$21,796
|
Figg, William
|
CCR (NCI)
|
|
Exploring the Therapeutic Potential of Stem Cell Biology in Gliomas
|
ZIABC010839
|
$382,264
|
$382,264
|
Fine, Howard
|
CCR (NCI)
|
|
Elucidation and Exploitation of GSK3 as a Novel Glioma Therapeutic Target
|
ZIABC010840
|
$382,264
|
$382,264
|
Fine, Howard
|
CCR (NCI)
|
|
Canine Glioma and Embryonic Neural Stem Cell Project
|
ZIABC011099
|
$445,975
|
$445,975
|
Fine, Howard
|
CCR (NCI)
|
|
SCF as a Novel CNS and Glioma-Derived Angiogenic Factor and SC Chemotaxic Factor
|
ZIABC011100
|
$445,975
|
$445,975
|
Fine, Howard
|
CCR (NCI)
|
|
Identifying New Glioma-Associated Tumor Suppressors and Oncogenes
|
ZIABC011101
|
$445,975
|
$445,975
|
Fine, Howard
|
CCR (NCI)
|
|
The Role of miRNAs in Glioma Stem Cell and Glioma Biology
|
ZIABC011102
|
$509,686
|
$509,686
|
Fine, Howard
|
CCR (NCI)
|
|
The Glioma Molecular Diagnostic Initiative: Characterizing Brain Tumor Data
|
ZIASC010100
|
$445,975
|
$445,975
|
Fine, Howard
|
CCR (NCI)
|
|
Brain Tumor Animal Therapeutics Core
|
ZICBC011086
|
$764,529
|
$764,529
|
Fine, Howard
|
CCR (NCI)
|
|
Brain Tumor Clinical and Clinical Research Program
|
ZIDBC011098
|
$2,548,429
|
$2,548,429
|
Fine, Howard
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIABC005598
|
$640,240
|
$96,036
|
Gottesman, Michael
|
CCR (NCI)
|
Total relevant funding to Nervous System for this search: $33,635,126
|